Recommendations of the Group on Hemostasis of the Polish Society of Hematology and Transfusiology are an update of the guidelines issued in 2008 [1]. In the absence of adequately designed randomized clinical trials for the diagnosis and treatment of von Willebrand disease, these recommendations are largely based on retrospective studies, expert opinions, series of case reports as well as guidelines published in other countries. In questionable cases, most conclusive for the final diagnosis of von Willebrand disease (VWD) is the physician’s experience and his assessment of the patient’s clinical picture.
CITATION STYLE
Zdziarska, J., Chojnowski, K., Klukowska, A., Łaguna, P., Łętowska, M., Mital, A., … Podolak-Dawidziak, M. (2022). Management of von Willebrand disease. Recommendations of the Hemostasis Group of the Polish Society of Hematology and Transfusiology (2022). Journal of Transfusion Medicine, 15(2), 75–99. https://doi.org/10.5603/jtm.2022.0009
Mendeley helps you to discover research relevant for your work.